Evaluation of Novel Multiplex Antibody Kit for Human Immunodeficiency Virus 1/2 and Hepatitis C Virus Using Sol-Gel Based Microarray

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Performance panel</td><td align="center">Number of panel members</td><td align="center">The Hi3-1 Multiplex kit</td><td align="center">The Architect system</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">PRB205 (anti-HIV 1 mixed titer panel)</td><td align="center">25</td><td align="center">22</td><td align="center">23</td></tr><tr><td align="left">PRF203 (anti-HIV 2 panel)</td><td align="center">11</td><td align="center">10</td><td align="center">10</td></tr><tr><td align="left">PHV106 (anti-HCV low titer panel)</td><td align="center">14</td><td align="center">10</td><td align="center">11</td></tr><tr><td align="left">PHV207 (anti-HCV mixed titer panel)</td><td align="center">25</td><td align="center">22</td><td align="center">23</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>Two samples of PRB205, one sample of PRF203, one sample of PHV 106, and two samples of PHV207 are characterized by the supplier as negative and were tested nonreactive by the Hi3-1 and the Architect assay.<br/></td></tr></table>

Comparison of the sensitivity between the Hi3-1 Multiplex and the Architect system with performance panel sera (panel 3). 

BioMed Research International

tab3

Table 3

Table 3: Evaluation of Novel Multiplex Antibody Kit for Human Immunodeficiency Virus 1/2 and Hepatitis C Virus Using Sol-Gel Based Microarray 